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Abstract
IMPORTANCE Dual decline in both memory and gait speed may characterize a group of older
individuals at high risk for future dementia.
OBJECTIVE To assess the risk of dementia in older persons who experience parallel declines in
memory and gait speed compared with those who experience no decline or decline in either memory
or gait speed only.
DESIGN, SETTING, AND PARTICIPANTS A multicohort meta-analysis was performed of 6
prospective cohort studies conducted between 1997 and 2018 in the United States and Europe.
Participants were 60 years or older, had an initial gait speed of more than 0.6 m/s (ie, free of overt
dismobility), with repeated measures of memory and gait speed before dementia diagnosis during a
mean follow-up of 6.6 to 14.5 years. Within each study, participants were divided into 4 groups:
memory decline only, gait speed decline only, dual decline, or no decline (hereafter referred to as
usual agers). Gait decline was defined as a loss of 0.05 m/s or more per year; memory decline was
defined as being in the cohort-specific lowest tertile of annualized change.
MAIN OUTCOMES AND MEASURES Risk of incident dementia according to group membership was
examined by Cox proportional hazards regression with usual agers as the reference, adjusted for
baseline age, sex, race/ethnicity, educational level, study site, and baseline gait speed and memory.
RESULTS Across the 6 studies of 8699 participants, mean age ranged between 70 and 74 years and
mean gait speed ranged between 1.05 and 1.26 m/s. Incident dementia ranged from 5 to 21 per 1000
person-years. Compared with usual agers, participants with only memory decline had 2.2 to 4.6
times higher risk for developing dementia (pooled hazard ratio, 3.45 [95% CI, 2.45-4.86]). Those
with only gait decline had 2.1 to 3.6 times higher risk (pooled hazard ratio, 2.24 [95% CI, 1.62-3.09]).
Those with dual decline had 5.2 to 11.7 times the risk (pooled hazard ratio, 6.28 [95% CI, 4.56-8.64]).
CONCLUSIONS AND RELEVANCE In this study, dual decline of memory and gait speed was
associated with increased risk of developing dementia among older individuals, which might be a
potentially valuable group for preventive or therapeutic interventions. Why dual decline is associated
with an elevated risk of dementia and whether these individuals progress to dementia through
specific mechanisms should be investigated by future studies.
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Key Points
Question Is a decline in both memory
and gait speed with aging associated
with a higher risk of dementia than no
decline or a decline in memory or gait
only in older adults?
Findings In this meta-analysis of 6
studies including 8699 participants
from the United States and Europe, a
decline in both memory and gait was
associated with 6.28 times higher risk of
developing dementia than no decline.
Meaning Older adults without
dementia with parallel declines in
memory and gait are associated with
high risk of developing dementia and
may be a group to target for prevention.
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Introduction
Impaired mobility, such as slow gait, is associated with an increased risk of dementia, but the effect
size of this association is generally modest.1-6 Identifying persons who experience both mobility
decline and memory decline, a main symptom in the early stage of dementia, may have a greater
prognostic value in assessing risk of dementia because the combination could identify a group in
whom gait speed decline is at least in part caused by neurodegenerative pathologic conditions of the
central nervous system rather than local musculoskeletal problems, such as sarcopenia or
osteoarthritis.7-9 A recent study of 154 participants with mild cognitive impairment reported that
those who declined in both cognition and gait speed had the highest risk of dementia.10 However,
this study population was limited to a relatively small clinical sample admitted to geriatric clinics.
Whether this association occurs in general aging populations initially free of dismobility and cognitive
impairment is unknown. If such an association is confirmed, it may help to identify older individuals
who are free of dismobility and cognitive impairment but at high risk of developing dementia. It could
also motivate investigations into whether this group develops dementia through specific
pathophysiological mechanisms.
A growing line of research suggests that motoric cognitive risk syndrome, a combination of
cognitive decline, slow gait, and preserved activities of daily living, is associated with high risks of
cognitive impairment and dementia.11-14 However, motoric cognitive risk syndrome is typically
operationalized at 1 time point. Recent evidence suggests that assessing gait speed longitudinally
rather than with a 1-time assessment better distinguishes individuals who develop dementia.10
To address these knowledge gaps, we examined whether the extreme phenotype of dual
decline in memory and gait with aging compared with no decline or decline in gait or memory only
would be associated with an increased risk of dementia among community-dwelling older adults. We
used data from 6 prospective cohort studies in the United States and Europe to create an individual-
level meta-analysis. To capture early memory and gait changes with aging, we identified participants
aged 60 years or older who were initially free of dismobility, cognitive impairment, and dementia;
tracked changes in memory and gait speed during the dementia-free period; and then captured
incident dementia. We hypothesized that those who experienced a decline in both memory and gait




We used individual-level data from 6 prospective cohort studies: the Baltimore Longitudinal Study of
Aging (BLSA)15; the Health, Aging and Body Composition Study (Health ABC)16; the Mayo Clinic Study
of Aging (MCSA)17; the Age, Gene/Environment Susceptibility-Reykjavik Study (AGES-RS)18; the
InCHIANTI (Invecchiare in Chianti, Aging in the Chianti Area) study19; and the Swedish National Study
on Aging and Care-Kungsholmen Population Study (SNAC-K).20 The years of data collection ranged
between 1997 and 2018. All studies were conducted under the oversight and approval of the
institutional review boards of the institutions that conducted them. All participants consented to
participate after receiving a comprehensive description of the study, including possible risks. This
meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses
(PRISMA) reporting guideline.
We excluded participants who, at baseline, had prevalent cognitive impairment, dementia, and
dismobility (gait speed 0.6 m/s)21 and who had baseline Mini-Mental State Examination (MMSE)
scores of less than 2422 (BLSA, MCSA, AGES-RS, InCHIANTI, and SNAC-K) or Modified Mini-Mental
State Examination scores of less than 80 (Health ABC).23 Mild cognitive impairment or cognitive
impairment was diagnosed by consensus conferences following published criteria in BLSA,24
MCSA,25 AGES-RS,26 and InCHIANTI.19 We further excluded participants who did not have repeated
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measures of memory and gait speed prior to diagnoses of dementia, last follow-up, or death because,
for these individuals, we could not estimate annualized changes in memory and gait speed.
Phenotypic Groups
Within each study, participants were classified into 4 phenotypic groups based on annualized
changes in memory and gait speed prior to diagnoses of dementia, last follow-up, or death. Usual gait
speed for a distance of 7.6 m (25 ft) in MCSA or a distance of 6 m in all other studies was used for
analysis. Gait speed was harmonized to the same unit in meters per second. Specifically, in
InCHIANTI, we converted a 4-m gait speed to a 6-m gait speed.27 In Health ABC, we converted a
20-m gait speed assessed at years 2, 3, 5, and 8 to a 6-m gait speed.28 In MCSA, gait speed was
simply expressed as meters (25 ft; 7.62 m) divided by time in seconds.29 Except in MCSA and SNAC-K,
which conducted only 1 trial, usual gait speed was assessed in 2 trials, and the faster trial was used
for analysis.
Across the 6 studies, we focused on verbal episodic memory when available, especially
immediate recall, because it was among the first cognitive functions to decline among Alzheimer
disease–related cognitive measures.30 Specifically, memory was assessed using the California Verbal
Learning Test in BLSA,31 the Buschke Selective Reminding Test in Health ABC,32 the Rey Verbal
Learning Test in MCSA,17,33 the modified California Verbal Learning Test in AGES-RS,31 the MMSE
memory subscore in InCHIANTI,34 and a free recall test in SNAC-K.35
Outcome
Dementia was ascertained based on the Diagnostic and Statistical Manual of Mental Disorders (Third
Edition Revised)36 in BLSA; the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition)
(DSM-IV) in MCSA and SNAC-K; race-specific decline in Modified Mini-Mental State Examination
scores, medication use, and hospital records in Health ABC37; a 3-step consensus adjudication
following DSM-IV criteria in AGES-RS18; and a 2-stage screening procedure following DSM-IV criteria
in InCHIANTI.38 Within each study, the end point was at diagnoses of dementia for those who
developed dementia or at last follow-up or death for those who did not develop dementia. Detailed
assessment and study designs are presented in eTable 1 in the Supplement.
Statistical Analysis
Within each study, annual rates of change in memory and gait speed prior to diagnoses of dementia,
last follow-up, or death were first computed using simple linear regression. Participants were then
classified into 4 phenotypic groups, using cut points of annualized decline in gait speed equal to or
greater than 0.05 m/s39 and the lowest tertile of annualized decline in memory performance.
Specifically, those with less than 0.05 m/s annualized decline in gait speed and in the middle and
highest tertiles (ie, less decline) of annualized decline in memory were referred to as usual agers.
Those with less than 0.05 m/s annualized decline in gait speed but in the lowest tertile of annualized
decline in memory were referred to as participants with memory decline only. Those with equal to
or greater than 0.05 m/s annualized decline in gait speed and in the middle and highest tertile of
annualized decline in memory were referred to as participants with gait decline only. Those with
equal to or greater than 0.05 m/s annualized decline in gait speed and in the lowest tertile of
annualized decline in memory were referred to as participants with dual decline. In InCHIANTI,
individual slopes of MMSE memory subscores were estimated using a random-effects Poisson model
owing to its distribution.
We first examined whether baseline gait speed and memory differed between groups, using
multiple linear regression with usual agers being the reference group, adjusting for baseline age, sex,
educational level, race/ethnicity, and study site. We then examined associations of baseline gait
speed and memory performance with incident dementia using Cox proportional hazards regression,
accounting for demographic characteristics.
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We examined associations of phenotypic groups with incident dementia using Cox proportional
hazards regression, with usual agers being the reference group, adjusting for demographic
characteristics and baseline gait speed and memory performance. In Health ABC, because Buschke
Selective Reminding Test began at year 3, the estimated intercept at baseline by simple linear
regression was used as the covariate.
The mean risk of dementia among participants with memory decline, participants with gait
decline, and participants with dual decline across the 6 studies was examined using random-effects
meta-analysis, following guidelines from the Cochrane Handbook for Systematic Reviews of
Interventions.40 The findings are presented as forest plots and reported following published
guidelines.41 Heterogeneity among studies was examined using the Cochrane χ2 test. The amount of
variation across studies that was due to heterogeneity was indicated by I2, expressed as a
percentage. We performed sensitivity analyses by excluding 2 studies in which dementia was
ascertained a posteriori (Health ABC and InCHIANTI). We performed additional sensitivity analyses
by adjusting for baseline multimorbidity and specific diseases important for declines in memory and
gait, including hypertension, cardiovascular disease, and stroke.
To evaluate whether changes in gait speed and memory added prognostic value beyond
baseline gait speed and memory, we compared 2 models using likelihood ratio tests. To examine
whether the risk of dementia associated with gait decline was similar for those with and those
without memory decline, we added an interaction term between slope of memory decline and slope
of gait decline in Cox proportional hazards regression. A significant interaction would reject the null
hypothesis that the risk of developing dementia associated with gait decline was the same for
participants with and participants without memory decline.
Statistical analyses were performed using SAS, version 9.4 (SAS Institute Inc) and R, version
3.5.0 (R Project for Statistical Computing). All P values were from 2-sided tests and results were
deemed statistically significant at P < .05.
Results
All 6 studies of 8699 participants included both men and women (Table 1). The BLSA and Health ABC
study populations were racially/ethnically diverse and included a substantial proportion of black
participants. Other studies had almost all or exclusively white participants. At baseline, the mean age
across studies ranged between 70 and 74 years. The mean gait speed ranged between 1.05 and 1.26
m/s. The mean follow-up time ranged between 6.6 and 14.5 years. Across the 6 studies of 8699
participants, incident dementia ranged from 5 to 21 per 1000 person-years.
Compared with usual agers, after adjustment, participants with gait decline and participants
with dual decline had faster baseline gait speed in all studies except InCHIANTI. Baseline gait speed
did not differ between participants with memory decline and usual agers in all studies (eTable 2 in the
Supplement).
Compared with usual agers, participants with memory decline and participants with dual
decline had higher baseline memory performance in all studies except InCHIANTI and BLSA. Baseline
memory did not differ between participants with gait decline and usual agers except in Health ABC,
in which participants with gait decline had poorer baseline memory performance (eTable 2 in the
Supplement).
After adjustment, poorer baseline memory performance was associated with a higher risk of
developing dementia in all studies except InCHIANTI. Slower baseline gait speed was associated with
a higher risk of dementia in all studies except BLSA (Table 2; model 1).
Compared with usual agers, participants with dual decline and participants with memory
decline had a significantly higher risk of developing dementia consistently across all studies after
adjustment for demographic characteristics and baseline memory and gait speed (Table 2; model 2;
eFigure in the Supplement). Specifically, participants with dual decline had 5.2 to 11.7 times higher risk
of developing dementia compared with usual agers, with a pooled hazard ratio (HR) of 6.28 (95% CI,
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4.56-8.64) (Figure, C).15-20 Participants with only memory decline had 2.2 to 4.6 times higher risk,
with a pooled HR of 3.45 (95% CI, 2.45-4.86) (Figure, A).15-20 Participants with only gait decline had
2.1 to 3.6 times the risk (pooled HR, 2.24; 95% CI, 1.62-3.09) (Figure, B).15-20 Associations of gait
decline with dementia risk were significant in Health ABC, InCHIANTI, and SNAC-K but not significant
in BLSA, MCSA, and AGES-RS. Meta-analyses results remained similar after excluding 2 studies in
which dementia was ascertained a posteriori: compared with usual agers, participants with dual
decline had a pooled HR of 5.40 (95% CI, 4.95-5.89), participants with only memory decline had a
pooled HR of 3.62 (95% CI, 2.22-5.90), and participants with only gait decline had a pooled HR of
2.01 (95% CI, 1.36-2.98). Adjustment for multimorbidity and specific diseases did not substantially
alter the results (eTable 3 in the Supplement).
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Stockholm, Sweden
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Women, No. (%) 329 (50) 371 (51) 1266 (48) 1491 (58) 293 (53) 947 (61)
Black race/ethnicity, No. (%) 140 (21) 315 (43) 5 (0.2) 0 0 0
Educational level,
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Phenotypic groups, No. (%)
No memory or gait speed
decline
375 (56) 422 (58) 1383 (53) 1519 (59) 291 (53) 674 (43)
Memory decline only 170 (26) 202 (28) 616 (23) 743 (29) 164 (30) 309 (20)
Gait decline only 67 (10) 63 (9) 373 (14) 177 (7) 61 (11) 365 (23)
Dual decline in memory
and gait speed
52 (8) 40 (6) 261 (10) 124 (5) 37 (7) 211 (14)
Abbreviations: 3MS, Modified Mini-Mental State Examination; AGES-RS, Age, Gene/
Environment Susceptibility-Reykjavik Study; AVLT, Auditory Verbal Learning Test; BLSA,
Baltimore Longitudinal Study of Aging; CVLT, California Verbal Learning Test; Health ABC,
Health, Aging and Body Composition Study; InCHIANTI, Invecchiare in Chianti, Aging in
the Chianti Area; IQR, interquartile range; MCSA, Mayo Clinic Study of Aging; MMSE,
Mini-Mental State Examination; SNAC-K, The Swedish National Study on Aging and Care
in Kungsholmen; SRT, Buschke Selective Reminding Test.
a The initial assessment of 6-m gait speed started in 2006, although the BLSA began in
1958. The sample in the Health ABC is from the Cognitive Vitality Substudy.
b Calculated as weight in kilograms divided by height in meters squared.
c A higher score indicates higher performance. The range of possible scores is 0 to 30 for
the MMSE and 0 to 100 for the 3MS.
d The MMSE memory subscore is shown as median (IQR).
e A higher value indicate higher performance.
f Only visits where memory function and gait speed were assessed and used to define
the phenotypic classification.
g In AGES-RS, gait and memory were assessed only twice with a mean (SD) interval of 5
(0.3) years.
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Based on likelihood ratio tests performed consistently across the 6 studies, models including
information on change over time yielded a lower Akaike information criterion and a significant model
change compared with models including information on baseline gait speed and baseline memory
only, indicating a better fit (eTable 4 in the Supplement).
In BLSA, Health ABC, and SNAC-K, the interaction between slope of memory decline and slope
of gait decline was significant in Cox proportional hazards regression models associated with
dementia risk (BLSA: β [SE], –1.285 [0.495]; P = .01; Health ABC: β [SE], –3.071 [1.137]; P = .006; and
SNAC-K: β [SE], –7.590 [2.403]; P = .001). In MCSA, findings were not significant (β [SE], 0.595
[0.362]; P = .10). In AGES-RS and InCHIANTI, the interaction term was also not significant (AGES-RS:
β [SE], 2.10 [1.51]; P = .16; InCHIANTI: β [SE], –0.053 [0.053]; P = .31 [in InCHIANTI, the slope of gait
and slope of memory (by Poisson) were multiplied by 100 owing to small values]).
Discussion
Across 6 large cohort studies of aging, dual decline in both memory and gait speed during the
dementia-free period was associated with high risk of developing dementia. Our findings are
consistent with the recent report by Montero-Odasso and colleagues.10 Our data further contribute
to the literature by confirming these findings in 6 geographically and culturally diverse aging studies,
focusing on memory function, rather than global cognition, and by characterizing early phenotype
when participants are free of dismobility, cognitive impairment, and dementia.
Poorer baseline memory was associated with a higher risk of dementia except in InCHIANTI. The
lack of an association in InCHIANTI may be due to the use of the MMSE memory subscore, a poorly
sensitive measure of memory. In all studies except BLSA, slower baseline gait speed was associated
with a higher risk of dementia, consistent with prior findings.1 The lack of an association in BLSA
Table 2. Associations of Phenotypic Groups With Subsequent Dementia Riska
Phenotype
BLSA (N = 664) Health ABC (N = 727) MCSA (N = 2633) AGES-RS (N = 2563) InCHIANTI (N = 553) SNAC-K (N = 1559)























































































































Abbreviations: AGES-RS, Age, Gene/Environment Susceptibility-Reykjavik Study; BLSA,
Baltimore Longitudinal Study of Aging; Health ABC, Health, Aging and Body Composition
Study; HR, hazard ratio; InCHIANTI, Invecchiare in Chianti, Aging in the Chianti Area;
MCSA, Mayo Clinic Study of Aging; NA, not applicable; SNAC-K, The Swedish National
Study on Aging and Care in Kungsholmen.
a All models were adjusted for baseline age, sex, and educational level in all studies;
additionally adjusted for race/ethnicity in BLSA, Health ABC, and MCSA; and
additionally adjusted for site in Health ABC and InCHIANTI.
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supports the notion that a 1-time gait speed assessment may be less able than change over time to
assess risk of dementia.10 In all 6 studies, models with change over time significantly improved the
assessment of the risk of dementia than models with only information on baseline gait speed and
memory. Thus, tracking changes over time may add important information in assessing the risk of
developing dementia beyond obtaining a 1-time assessment.
As expected, participants with memory decline had an increased risk of dementia consistently
across the 6 cohorts. Our focus on verbal episodic memory, especially immediate recall, rather than
global cognition or mental status, allows us to capture early memory decline among Alzheimer
disease–related cognitive measures within aging. Focusing on memory, rather than executive
function or processing speed, also allows us to better differentiate phenotypic groups because gait
speed is associated with executive function within cognitive domains.42
Although participants with gait decline also showed some increased risk of dementia, when
accompanied by a parallel decline in objective memory, the risk of developing dementia tended to be
the highest among phenotypic groups. Our finding that participants with dual decline are at








































































































































































A, Participants with only memory decline compared
with those with no decline in memory or gait speed. B,
Participants with gait decline only compared with
those with no decline in memory or gait speed. C,
Participants with dual decline compared with those
with no decline in memory or gait speed. The sizes of
the data markers indicate the size of each study; the
larger the data marker, the more participants were in
the study. The vertical dashed line in each panel shows
the overall measure of effect. AGES-RS indicates the
Age, Gene/Environment Susceptibility-Reykjavik
Study; BLSA, the Baltimore Longitudinal Study of
Aging; Health ABC, the Health, Aging and Body
Composition Study; InCHIANTI, Invecchiare in Chianti,
Aging in the Chianti Area; MCSA, the Mayo Clinic Study
of Aging; and SNAC-K, the Swedish National Study on
Aging and Care-Kungsholmen Population Study. SE
indicates standard error.
JAMA Network Open | Geriatrics Association of Dual Decline in Memory and Gait Speed With Risk for Dementia
JAMA Network Open. 2020;3(2):e1921636. doi:10.1001/jamanetworkopen.2019.21636 (Reprinted) February 21, 2020 7/13
Downloaded From: https://jamanetwork.com/ on 01/26/2021
particularly high risk of developing dementia supports the importance of the unique occurring
symptom of cognitive and motor deficits outlined in previous research on motoric cognitive risk
syndrome and further establishes its clinical relevance. Among older adults living in the community
free of cognitive impairment and dismobility, the dual decline phenotype can be captured early in
clinical settings by routinely administering gait speed assessment and a free recall memory test.43 At
this stage, this group should be carefully evaluated for potentially reversible risk factors for dementia.
However, research focusing on biological and physiological characteristics that explain why individual
with dual decline are at such high risk of developing dementia may lead to new opportunities for
prevention.
Our findings add weight to the hypothesis that dual decline with aging represents some shared
underlying processes associated with declines in both gait and memory that are associated with
ultimate overt dementia. Our study may provide a possible explanation for the heterogeneity of
reported findings.1,3 Perhaps gait speed decline is associated with dementia most particularly when
it is at least in part due to incipient central nervous system pathologic characteristics. Our findings
that participants with dual decline have the highest risk of dementia capture the critical need for
tracking gait and memory and may help isolate potential central nervous system causes of gait
decline. An interesting hypothesis is that dual decline may characterize older persons who will
eventually progress to dementia through specific pathophysiological mechanisms. Although the
nature of these mechanisms is not yet known, we propose that vascular, metabolic, or energetic
dysfunction is the likely factor.44-55 This hypothesis should be tested in further studies by examining
the particular metabolic, vascular, and neuroimaging features that characterize this specific group.
Our findings do not necessarily address the question as to whether the high risk of dementia
associated with dual decline is simply due to the combination of 2 independent factors, gait decline
and memory decline, or whether the increased risk represents a shared underlying pathologic
condition. Findings varied across the 6 cohorts. Specifically, while the relative risk of dementia
associated with dual decline was always higher than the sum of risks due to gait decline and memory
decline, the interaction between gait decline and memory decline was significant in 3 studies (BLSA,
Health ABC, and SNAC-K). In studies that demonstrated a significant interaction, the period in which
gait and memory were assessed was relatively long (mean period, 6-9 years) vs AGES-RS and MCSA
(5 years). Although InCHIANTI also had a relatively long period of time assessing gait and memory (9
years), it was somewhat limited by the insensitive measure of memory, based only on the MMSE
memory subscore.
Strengths and Limitations
This study has numerous strengths: use of multiple large longitudinal cohort studies, efforts to
harmonize measures, careful delineation of individual study approaches to dementia diagnosis, and
use of rigorous meta-analytic measures. Accounting for multimorbidity and specific diseases, such as
hypertension, cardiovascular disease, and stroke, enriched the analyses, and the findings remained
robust. Although a posteriori ascertainment of dementia in 2 studies may have overestimated
incident cases, the results remained largely unchanged after excluding these 2 studies.
This study also has some limitations. We acknowledge a lack of information on subtypes of
dementia in some studies; thus, we could not evaluate the risk of dementia subtypes. Second, the
specific memory measures that we examined in InCHIANTI and MCSA are partly used in dementia
diagnostic procedures. However, in InCHIANTI, the MMSE is not the only assessment used to
ascertain dementia, and our study used the memory subscore. In MCSA, information from the Rey
Verbal Learning Test among all other neuropsychological tests contributed to the determination of a
dementia diagnosis.17 In the other 4 studies, the memory measures that we used in this study are
not used in their dementia diagnostic algorithms. Another potential limitation is the possibility of
regression to the mean. In some studies, participants with dual decline had higher baseline gait speed
and memory performance than usual agers. Participants with dual decline who had higher baseline
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gait and memory may have had more room to decline than those with lower baseline performance.
However, by adjusting for baseline gait speed and memory, we minimized this possibility.
Conclusions
Our findings have relevant clinical implications and provide important contributions to research on
early signs of an underlying dementia process. Older persons with dual decline in memory and gait
speed should receive further attention to address issues that may increase dementia risk, including
evaluation of cardiovascular and metabolic risk factors. Studying the cardiovascular and metabolic
characteristic of this subgroup may provide clues to the specific mechanisms that confer high risk of
dementia. Dual decline in memory and gait speed was associated with high risk of developing
dementia. These individuals might serve as a valuable target for preventive interventions. Why
individual with dual decline are at such a high risk of developing dementia and whether they progress
to dementia through distinct mechanisms are not yet known and deserve further investigation.
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